Development of a FLP/frt System for Generating Helper-Dependent Adenoviral Vectors

This publication has 30 references indexed in Scilit:

• Prolonged Expression and Effective Readministration of Erythropoietin Delivered with a Fully Deleted Adenoviral Vector
  Human Gene Therapy, 2000
• High Doses of a Helper-Dependent Adenoviral Vector Yield Supraphysiological Levels ofα₁-Antitrypsin with Negligible Toxicity
  Human Gene Therapy, 1998
• Genomic DNA transfer with a high-capacity adenovirus vector results in improved in vivo gene expression and decreased toxicity
  Nature Genetics, 1998
• Immune Responses to Reporter Proteins and High Viral Dose Limit Duration of Expression with Adenoviral Vectors: Comparison of E2a Wild Type and E2a Deleted Vectors
  Human Gene Therapy, 1997
• Human Adenovirus Vectors for Gene Transfer into Mammalian Cells
  Published by Elsevier ,1997
• Innate Immune Mechanisms Dominate Elimination of Adenoviral Vectors FollowingIn VivoAdministration
  Human Gene Therapy, 1997
• Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy.
  Proceedings of the National Academy of Sciences, 1994
• Recombination within the yeast plasmid 2μ circle is site-specific
  Cell, 1982
• Characteristics of a Human Cell Line Transformed by DNA from Human Adenovirus Type 5
  Journal of General Virology, 1977
• A new technique for the assay of infectivity of human adenovirus 5 DNA
  Virology, 1973